Vertex Pharmaceuticals Inc (VRTX) financials · P/E 30, rev $12.00B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Vertex Pharmaceuticals Inc (VRTX) P/E 30, rev $12.00B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $12.00B | $11.02B |
| Cost of Revenue | $1.65B | $1.53B |
| Gross Profit | $10.35B | $9.49B |
| Operating Income | $4.17B | -$232.9M |
| Net Income | $3.95B | -$535.6M |
| EPS (Diluted) | $15.32 | -$2.08 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $25.64B | $22.53B |
| Current Assets | $11.20B | $9.60B |
| Cash & Equivalents | $5.08B | $4.57B |
| Inventory | $1.69B | $1.21B |
| Total Liabilities | $6.98B | $6.12B |
| Current Liabilities | $3.86B | $3.56B |
| Shareholders' Equity | $18.67B | $16.41B |
| Retained Earnings | $13.56B | $9.61B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $3.63B | -$492.6M |
| CapEx | $437.6M | $297.7M |
| Investing Cash Flow | -$945.4M | -$3.77B |
| Financing Cash Flow | -$2.26B | -$1.49B |
| Net Change in Cash | $515.6M | -$5.80B |
| Free Cash Flow | $3.19B | -$790.3M |
FAQ
What is VRTX P/E and revenue?
Vertex Pharmaceuticals Inc (VRTX) P/E 30, rev $12.00B.
What is VRTX revenue?
Vertex Pharmaceuticals Inc last cached revenue is $12.00B (FY2025).
Is VRTX profitable?
Vertex Pharmaceuticals Inc last cached net income is $3.95B (FY2025).
What are VRTX total assets?
Vertex Pharmaceuticals Inc last cached total assets are $25.64B (FY2025).
What is VRTX free cash flow?
Vertex Pharmaceuticals Inc last cached free cash flow is $3.19B (FY2025).
Not investment advice. Cached statements, not a live tape.